Phosphatidic acid and not diacylglycerol generated by phospholipase D is functionally linked to the activation of the NADPH oxidase by FMLP in human neutrophils.
It is widely accepted that the activation of the NADPH oxidase of phagocytes is linked to the stimulation of protein kinase C by diacylglycerol formed by hydrolysis of phospholipids. The main source would be choline containing phospholipid via phospholipase D and phosphatidate phosphohydrolase. This paper presents a condition where the activation of the respiratory burst by FMLP correlates with the formation of phosphatidic acid, via phospholipase D, and not with that of diacylglycerol. In fact: 1) in neutrophils treated with propranolol, an inhibitor of phosphatidate phosphohydrolase, FMLP plus cytochalasin B induces a respiratory burst associated with a stimulation of phospholipase D, formation of phosphatidic acid and complete inhibition of that of diacylglycerol. 2) The respiratory burst by FMLP plus cytochalasin B lasts a few minutes and may be restimulated by propranolol which induces an accumulation of phosphatidic acid. 3) In neutrophils stimulated by FMLP in the absence of cytochalasin B propranolol causes an accumulation of phosphatidic acid and a marked enhancement of the respiratory burst without formation of diacylglycerol. 4) The inhibition of the formation of phosphatidic acid via phospholipase D by butanol inhibits the respiratory burst by FMLP.
Rossi
F
F
Institute of General Pathology, University of Verona, Italy.
Grzeskowiak
M
M
Della Bianca
V
V
Calzetti
F
F
Gandini
G
G
D000440:Butanols / Q000494:pharmacology; D003571:Cytochalasin B / Q000494:pharmacology; D004075:Diglycerides / Q000502:physiology*; D004789:Enzyme Activation / Q000187:drug effects; D005989:Glycerides / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism*; D019255:NADPH Oxidases; D009504:Neutrophils / Q000502:physiology*; D010101:Oxygen Consumption / Q000187:drug effects; D010712:Phosphatidic Acids / Q000502:physiology*; D010739:Phospholipase D / Q000502:physiology*; D010740:Phospholipases / Q000502:physiology*; D011433:Propranolol / Q000494:pharmacology
D000440:Butanols; D004075:Diglycerides; D005989:Glycerides; D010712:Phosphatidic Acids; D003571:Cytochalasin B; D009240:N-Formylmethionine Leucyl-Phenylalanine; D011433:Propranolol; D009247:NADH, NADPH Oxidoreductases; D019255:NADPH Oxidases; D010740:Phospholipases; D010739:Phospholipase D